Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach

被引:16
|
作者
Meng Zi-qi [1 ]
Wu Jia-rui [1 ]
Zhu Ying-li [1 ]
Zhou Wei [1 ]
Fu Chang-geng [2 ]
Liu Xin-kui [1 ]
Liu Shu-yu [1 ]
Ni Meng-wei [1 ]
Guo Si-yu [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Mat Med, Dept Clin Chinese Pharm, Beijing 100029, Peoples R China
[2] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing 100091, Peoples R China
基金
中国国家自然科学基金;
关键词
scutellarin; angina pectoris; ischemic stroke; network pharmacology; UPDATE; CELLS; BRAIN; BREVISCAPINE; DYSFUNCTION; ACTIVATION; DISEASES; DATABASE; EXTRACT; AGENT;
D O I
10.1007/s11655-020-2716-4
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective To investigate the shared mechanisms of scutellarin in angina pectoris (AP) and ischemic stroke (IS) treatment. Methods A network pharmacology approach was used to detect the potential mechanisms of scutellarin in AP and IS treatment by target prediction, protein-protein interaction (PPI) data collection, network construction, network analysis, and enrichment analysis. Furthermore, molecular docking simulation was employed to analyze the interaction between scutellarin and core targets. Results Two networks were established, including a disease-target network and a PPI network of scutellarin targets against AP and IS. Network analysis showed that 14 targets, namely, AKT1, VEGFA, JUN, ALB, MTOR, ESR1, MAPK8, HSP90AA1, NOS3, SERPINE1, FGA, F2, FOXO3, and STAT1, might be the therapeutic targets of scutellarin in AP and IS. Among them, NOS3 and F2 were recognized as the core targets. Additionally, molecular docking simulation confifirmed that scutellarin exhibited a relatively high potential for binding to the active sites of NOS3 and F2. Furthermore, enrichment analysis indicated that scutellarin might exert a therapeutic role in both AP and IS by regulating several important pathways, such as coagulation cascades, mitogen-activated protein kinase (MAPK) signaling pathway, phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, Toll-like receptor signaling pathway, hypoxia inducible factor-1 (HIF-1) signaling pathway, forkhead box O (FoxO) signaling pathway, tumor necrosis factor (TNF) signaling pathway, adipocytokine signaling pathway, insulin signaling pathway, insulin resistance, and estrogen signaling pathway. Conclusions The shared underlying mechanisms of scutellarin on AP and IS treatment might be strongly associated with its vasorelaxant, anticoagulant, anti-inflammatory, and antioxidative effects as well as its effect on improving lipid metabolism.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 50 条
  • [11] Kuanxiong Aerosol(宽胸气雾剂) in Treatment of Angina Pectoris:A Literature Review and Network Pharmacology
    ZHANG Yuzhuo
    ZENG Ruixiang
    ZHOU Yuanshen
    ZHANG Minzhou
    Chinese Journal of Integrative Medicine , 2021, (06) : 470 - 480
  • [12] Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Buyang Huanwu Decoction in the Treatment of Ischemic Stroke
    Gao, Qiang
    Tian, Danfeng
    Han, Zhenyun
    Lin, Jingfeng
    Chang, Ze
    Zhang, Dandan
    Ma, Dayong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [13] Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Gastrodia elata Blume in the treatment of ischemic stroke
    Luo, Yuan
    Chen, Pu
    Yang, Liping
    Duan, Xiaohua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (06)
  • [14] Exploring Mechanisms of Houshiheisan in Treating Ischemic Stroke with Network Pharmacology and Independent Cascade Model
    Cao, Bo
    Jin, Jiao
    Tang, Zhiyu
    Luo, Qiong
    An, Jinbing
    Pang, Wei
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (07) : 959 - 968
  • [15] Identification of Potential Bioactive Ingredients and Mechanisms of the Guanxin Suhe Pill on Angina Pectoris by Integrating Network Pharmacology and Molecular Docking
    Wang, Mingmin
    Yang, Shuangjie
    Shao, Mingyan
    Zhang, Qian
    Wang, Xiaoping
    Lu, Linghui
    Gao, Sheng
    Wang, Yong
    Wang, Wei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [16] Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina
    Guo-xia Zhang
    Ying-ying Zhang
    Xiao-xu Zhang
    Peng-qian Wang
    Jun Liu
    Qiong Liu
    Zhong Wang
    Acta Pharmacologica Sinica, 2018, 39 : 952 - 960
  • [17] Screening of liothyronine network pharmacology role in the treatment of ischemic stroke and molecular mechanism
    Yuan, Li
    Xiao, Dongdong
    Yang, Rumei
    Ge, Lei
    Wan, Yuye
    Jiang, Lianglei
    ENVIRONMENTAL TOXICOLOGY, 2024, 39 (03) : 1641 - 1649
  • [18] RETRACTION: A Network Pharmacology to Explore the Mechanism of Calculus Bovis in the Treatment of Ischemic Stroke
    Liu, F.
    Li, L.
    Chen, J.
    Wu, Y.
    Cao, Y.
    Zhong, P.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [19] Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina
    Zhang, Guo-xia
    Zhang, Ying-ying
    Zhang, Xiao-xu
    Wang, Peng-qian
    Liu, Jun
    Liu, Qiong
    Wang, Zhong
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (06) : 952 - 960
  • [20] Exploring the mechanisms under Zuogui Pill's treatment of ischemic stroke through network pharmacology and in vitro experimental verification
    Li, Li
    Liu, Yan
    Zheng, Yawei
    Zhu, Jian
    Wu, Dan
    Yan, Xiaohui
    Li, Changyin
    Wu, Minghua
    Li, Wenlei
    FRONTIERS IN PHARMACOLOGY, 2023, 14